Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spleen regeneration after subcutaneous heterotopic autotransplantation in a mouse model.
Elchaninov A, Vishnyakova P, Lokhonina A, Kiseleva V, Menyailo E, Antonova M, Mamedov A, Arutyunyan I, Bolshakova G, Goldshtein D, Bao X, Fatkhudinov T, Sukhikh G. Elchaninov A, et al. Among authors: mamedov a. Biol Res. 2023 Mar 29;56(1):15. doi: 10.1186/s40659-023-00427-4. Biol Res. 2023. PMID: 36991509 Free PMC article.
The spleen as a possible source of serine protease inhibitors and migrating monocytes required for liver regeneration after 70% resection in mice.
Elchaninov A, Vishnyakova P, Kuznetsova M, Gantsova E, Kiseleva V, Lokhonina A, Antonova M, Mamedov A, Soboleva A, Trofimov D, Fatkhudinov T, Sukhikh G. Elchaninov A, et al. Among authors: mamedov a. Front Cell Dev Biol. 2023 Sep 7;11:1241819. doi: 10.3389/fcell.2023.1241819. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37745290 Free PMC article.
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCE.
Buckstein R, Callum J, Prica A, Bowen D, Wells RA, Leber B, Heddle N, Chodirker L, Cheung M, Mozessohn L, Yee K, Gallagher J, Parmentier A, Jamula E, Zhang L, Mamedov A, Stanworth SJ, Lin Y. Buckstein R, et al. Among authors: mamedov a. Transfusion. 2024 Feb;64(2):223-235. doi: 10.1111/trf.17721. Epub 2024 Feb 7. Transfusion. 2024. PMID: 38323704 Clinical Trial.
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.
Buckstein R, Callum J, Prica A, Bowen D, Wells RA, Leber B, Heddle N, Chodirker L, Cheung M, Mozessohn L, Yee K, Gallagher J, Parmentier A, Jamula E, McQuilten Z, Wood EM, Weinkov R, Zhang L, Mamedov A, Stanworth SJ, Lin Y. Buckstein R, et al. Among authors: mamedov a. Am J Hematol. 2024 Mar;99(3):473-476. doi: 10.1002/ajh.27181. Epub 2023 Dec 21. Am J Hematol. 2024. PMID: 38126081 No abstract available.
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT).
Glicksman RM, Loblaw A, Morton G, Vesprini D, Szumacher E, Chung HT, Chu W, Liu SK, Tseng CL, Correa R, Deabreu A, Mamedov A, Zhang L, Cheung P. Glicksman RM, et al. Among authors: mamedov a. Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):100-109. doi: 10.1016/j.ijrobp.2023.11.006. Epub 2023 Nov 17. Int J Radiat Oncol Biol Phys. 2024. PMID: 37979707 Clinical Trial.
Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer.
Ong WL, Davidson M, Cheung P, Chung H, Chu W, Detsky J, Liu S, Morton G, Szumacher E, Tseng CL, Vesprini D, Ravi A, McGuffin M, Zhang L, Mamedov A, Deabreu A, Kulasingham-Poon M, Loblaw A. Ong WL, et al. Among authors: mamedov a. Radiother Oncol. 2023 Nov;188:109864. doi: 10.1016/j.radonc.2023.109864. Epub 2023 Aug 22. Radiother Oncol. 2023. PMID: 37619656
200 results